Amniotic fluid (AF) is formed at the very early stages of pregnancy, and is present throughout embryonic development of amniotes. It is wellknown that AF provides a protective sac around the fetus that allows fetal movement and growth, and prevents mechanical and thermal shock. However, a growing body of evidence has shown that AF contains a number of proteins and peptides, including growth factors and cytokines, which potently affect cellular growth and proliferation. In addition, pluripotent stem cells have recently been identified in AF. Herein, this article reviews the biological properties of AF during embryonic development and speculates that AF may act as a transporting pathway for signaling molecules and stem cells during amniote embryonic development. Defining this novel function of AF is potentially significant for further understanding embryonic development and regenerative medicine, preventing genetic diseases, and developing therapeutic options for human malignancies.
Introduction
Animals that possess an amnion are referred to as amniotes. The cavity between the amnion and the fetus is called the amniotic sac and contains amniotic fluid (AF). The amniotic sac is formed at very early stages and is present throughout embryonic development. 1 In humans, the amniotic sac and its aqueous fluid appear 7e8 days after fertilization. It is widely accepted that AF provides mechanical protection and nutrients. 2 Based on current literature and our own studies, 3, 4 this article hypothesizes that a potential important physiological role of AF may be to act as a transporting pathway for extracellular signaling molecules and stem cells during embryonic development.
Signaling molecules in embryonic induction
A fertilized oocyte divides into billions of cells that differentiate into diverse tissues and organs, resulting in the formation of a new organism. Embryonic induction is thought to play an important role in the development of tissues and organs in most animal embryos, from the lower chordates to the higher vertebrates. In principle, induction means any process in which the developmental pathway of one cell population is controlled by signals emitted from another. 5 Embryonic induction is further subcategorized into primary, secondary, and tertiary induction. 5 Primary embryonic induction includes neural and dorsal mesoderm inductions. The tissue interactions governing cell differentiation and morphogenesis throughout embryonic development are secondary and tertiary inductions; for example, the induction of the lens is classified as secondary induction. Induction is carried out through signaling molecules (regulatory messengers) or inducing factors. 6 These molecules are secreted into the extracellular space and target responding cells by specifically activating intracellular pathways. 7 To date, many extracellular signaling molecules and their corresponding intracellular pathways have been identified, including a variety of growth factors (ligands for tyrosine kinase receptor), transforming growth factor beta (TGF-b), hedgehog, notch, wingless, and retinoic acid. 6,8e10 They control cellular proliferation, differentiation, and other functions during development.
Most of the signaling molecules are proteins, and some are lipids or organic acids. It is generally accepted that these molecules are secreted by specialized groups of cells into the extracellular space and diffuse to neighboring cells. However, how these molecules reach target cells over long distances is not yet well understood.
3. AF may act as a transporting pathway for signaling molecules reaching target cells over long distances 3.1. Bi-directional substance exchange between AF and fetal tissues
In humans, the amniotic sac and fluid are formed during the blastocyst stages and are present throughout all embryonic stages.
1,2 AF is a dynamic milieu that undergoes multiple developmental changes over the duration of fetal growth. In early embryogenesis, AF mostly derives from the fetal extracellular matrix. Thereafter, production of AF is predominately accomplished by the excretions of fetal urine and secretion of skin, oral, nasal, tracheal, and pulmonary fluids. 1 There is rapid bidirectional exchange between the fetus and the amniotic cavity for solutes in AF by swallow, absorption, excretion, and secretion. A previous study demonstrated that intrafetally injected technetium Tc 99m rapidly enters and is concentrated in the amniotic cavity in fetal sheep at 131 days' gestation. Meanwhile, intraamniotically injected technetium Tc 99m rapidly enters into the fetal circulation. 11 To characterize the substance exchange between the AF and the fetal tissues, we injected phenol into the amniotic sacs of chick embryos at 16 days, and then detected the concentrations of phenol in the AF and fetal tissues. The results showed that phenol started to occur at 2 minutes in fetal tissues after injection of phenol into the AF, including the lung, liver, kidney, leg muscle, wing, brain, and eye. The concentration of phenol reached peak levels in these tissues at 5 minutes, began to decline at 6 minutes, and remained at stable levels at 10 minutes. The phenol concentrations from high to low order were revealed in the liver, lungs, heart, kidneys, leg muscles, wings, brain, and eyes. In contrast, the phenol level in the AF displayed an inverse pattern of changes compared to that observed in fetal tissues. It first rapidly decreased, then increased when levels declined in fetal tissues, and then reached a stable level at around 10 minutes. This result directly demonstrated that the solutes of AF rapidly bidirectionally exchange with all fetal tissues.
The composition of AF reflects the dynamic status of the developing fetus
AF contains electrolytes, carbohydrates, lipids, proteins, amino acids, lactate, pyruvate, enzymes, and hormones. We simultaneously measured the levels of the individual components, including electrolytes and organic substances in human AF, umbilical cord serum (UCS), and maternal serum (MS) from the same pregnant woman at 15e42 weeks' gestation. 3 The results showed that the level of primary electrolytes, such as sodium, chloride, and anion gap in AF were at almost the same level as in UCS and MS. The levels of organic substances in AF, including total protein, glucose, triglyceride, cholesterol, and various enzymes, were markedly lower than in UCS and MS. In addition, the osmotic pressure of AF was slightly lower than blood osmotic pressure. The data suggest that the composition of AF is not a simple filtrate from the blood, and AF is an independent fluid pool.
Almost all of the metabolites produced by fetal tissues have been found in AF. We have detected >100 metabolites, including cortisol, acetone, cholesterol butyrate, margaric acid, and H 3 -acetyl carnitine, etc., in AF using the gas chromatography-mass spectrometry (GC-MS) technique (unpublished data). Many fetal tissue-specific products have also been detected in AF and serve as biomarkers for fetal diseasespecific conditions. 12, 13 Simultaneous measurement of cytokines in AF and matching maternal sera has revealed that the concentrations of most cytokines are quite different from the maternal blood.
14 Proteomic analysis of AF also shows a significantly different composition from the maternal plasma. 15 These data indicate that the composition of AF is primarily representative of the fetal profile and reflects the physiological status of the developing fetus.
AF is indispensable for fetal development
Clinical data have demonstrated that abnormal AF volume is always associated with an increased risk of abnormal development or even death of the fetus. 16 Our study showed that replacement of 1.5 mL of AF with an equal volume of 37 C isosmotic saline in chick embryos at Day 14e15 definitely caused the death of all chick embryos. When the replacement was performed at Day 16e18, the exact time of chick leg and wing development, chicks were born alive, but unable to walk or move their wings. These phenomena suggest that AF plays an important role in embryonic development.
A large number of proteins and peptides in AF have been identified, and evidence has shown that most of these proteins or polypeptides have low molecular weights. 17 Among these proteins or peptides, an increasing number are identified as growth factors, tumor markers, and cytokines, which possess potent bioactivity. 18e22 The concentrations of these molecules in AF show a dynamic pattern during embryonic development. We monitored the levels of biomarkers including carcinoembryonic antigen, ferritin, cancer antigens 125 and 199, and alpha fetoprotein in human AF, and found that these proteins displayed different dynamic changes from those in the umbilical cord and maternal serum as gestation advanced. 3 Lei and Du 23 reported that the levels of epidermal growth factor in the human AF began to increase in the middle of pregnancy, ultimately reaching levels exceeding 4.5 mg/L before birth. Some studies have demonstrated that in early gestation, proteins could diffuse across unkeratinized fetal skin. 24 In late gestation, proteins within AF can be absorbed by the fetal gastrointestinal tract and transported to the whole fetal body. 25e27 The dynamic pattern and evidence for their transporting to the fetus imply that proteins in AF are required for fetal development.
The human AF proteome of a 16e18 week normal pregnancy was profiled by Cho et al 15 and the function of the fluid was analyzed by proteomic analysis. A total of 842 proteins and peptides were identified, functions of which included cellular movement, development of organs, and cellular growth and proliferation. It is known that the morphology and biological properties of embryonic cells are similar to those of tumor cells. We found that AF or proteins extracted from human AF at 20 weeks' gestation inhibited H22-hepatocarcinoma growth in a mouse model primarily through inducing tumor cells to adopt highly differentiated states. 4 A similar result has been reported by others with mouse AF. 28 The studies indicated that AF or AF-derived proteins or peptides were involved in the inducement of cellular differentiation. Moreover, we found the levels of total protein, glucose, and triglycerides in human AF were much lower than those in fetal and maternal sera. 3 For example, the average concentration of total protein in AF was 4.87 g/L, whereas it was 39.46 g/L and 61.55 g/L in fetal and maternal sera, respectively. The glucose level in AF was 1.29 mM, 3.45 mM in fetal, and 3.58 mM in maternal serum. Triglyceride and cholesterol were almost undetectable. These data suggest that AF may not act as a nutrient transporting pathway like it does in the blood circulation.
Hypothesis on the novel function of AF
Based on the characteristics of AF mentioned above, this article speculates that AF may act as a pathway for transporting signaling molecules to distant target cells. Embryonic development is a rapid process involved in extensive molecular expression and signaling transduction. Therefore, an independent and intact signaling delivering pathway is essential for embryogenesis. In amniotes, the allantois is part of the anal membrane, and forms an axis for the development of the umbilical cord. The stalk connecting the allantois to the fetal bladder eventually forms the bladder ligament after birth. Trophoblasts are cells that form the outer layer of the blastocyst and provide nutrients to the embryo. They develop into a large part of the placenta.
The fetal blood circulation transporting nutrients to all of the fetal tissues is unlikely to act as the pathway delivering signaling molecules. All of the molecules involved in embryogenesis are highly efficient, and they work at low concentrations. If these signaling molecules enter into fetal blood circulation, they would first go into the placenta, where substance in fetal blood exchanges with maternal circulation. This long distance circulation may delay these molecules from timely performing their actions, and they may also be diluted. In addition, they would be cleared out by the maternal immunological system in the placenta. Moreover, embryos do not form a blood circulation system at early stages. In contrast, AF is formed at very early stages of embryonic development and present through all embryonic stages. AF does not directly connect to the blood vascular system. All of the dissolved solutes in AF constantly directionally exchange with the fetus tissues. The composition of AF is a dynamic indicator of the embryonic metabolism and most of the identified proteins or peptides in AF have activities associated with cellular growth and proliferation. Those characteristics strongly support the view that the AF may act as a transporting pathway for signaling molecules in embryonic development.
AF may also act as a transporting pathway for stem cells

Debate about the origin of stem cells
The origins of fetal and adult stem cells are not yet well defined. 7 Many researchers have reported that stem cells isolated from bone marrow can differentiate into specialized cells, such as liver, muscle, or neural cells. Mesenchymal stem cells have been isolated from adult bone marrow; therefore, many scholars believe that both adult and fetal stem cells are originally produced by the bone marrow and then transferred to different tissues by the circulatory system. 29e31 Others believe that tissues retain a small proportion of undifferentiated or partially differentiated cells as progenitor cells, which act as a repair system for the body by replenishing adult tissues. 7 Although these two hypotheses are based on rational reviews and research data, this article suggests that both fetal and adult stem cells originate from a unique cell mass. This cell mass specifically produces stem cells that differentiate into diverse progenitor cells at different stages during embryonic development. Those diverse progenitor cell subtypes enter the amniotic cavity, then migrate through the AF and implant into specific tissues, where they will be maintained for life. Here we refer to the hypothesis as "the migration and implantation of stem cells by amniotic fluid". Some studies in mammals have shown that amniotic epithelial cells generate stem cells. 32, 33 Other reports suggest that stem cells originate from the yolk sac. 34 Some researchers believe that fetal stem cells are derived from the inner cell mass, 35 a view that is identical to our hypothesis. This article proposes that, whatever the derivative source of stem cells may be, it is unlikely that some stem cells would be maintained in an undifferentiated state, while other cells differentiate into specialized cell types during embryonic development. We cultured stem cells in vitro and found that different stem cells, including lipid, neural, and mesenchymal stem cells, had uniform phenotype after treatment with inducers. In other words, we never determined that some of the cells were differentiated while others were maintained in an undifferentiated state after induction. Obviously, this "all or none" phenomenon does not support the hypothesis that tissues retain stem cells by themselves. In addition, it is known that bone marrow is formed at the middle or late stages of embryonic development, while fetal stem cells appear at early stages of embryogenesis and are continuously produced until the end of embryonic development. Therefore, it is unlikely that bone marrow is an original source of stem cells.
A novel hypothesis on the origin of the stem cell and its transporting pathway
This article speculates that both fetal and adult stem cells may originate from a unique embryonic cell mass. This cell mass produces and releases a variety of subtypes of stem cells into the amniotic cavity at different stage of embryogenesis, which travel through AF, implanting into and residing in all tissues for a lifetime. The following evidence supports this hypothesis.
Cells from three embryonic layers (mesoderm, endoderm, and ectoderm) have been found in AF, including epithelial-like cells, amniotic and trophoblast cells that produce estrogen and chorionic gonadotropin, and mesenchymal fibroblast cells. 36, 37 Many scholars have isolated diverse progenitor cells from AF at early to late embryonic stages. 38 AF-derived stem cells (AFS) express embryonic and adult stem cell markers, including CD29, CD44, CD90, CD105, and CD73.
39e41 AFS rapidly proliferate and retain long telomeres and a normal karyotype after over 250 population doublings in culture in vitro. They can differentiate into cell types representing the three embryonic germ layers, including cells of adiopogenic, osteogenic, myogenic, endothelial, neuronal, and hepatic lineages after induction. Those characteristics fit the commonly accepted criteria for defining pluripotent stem cells. 42, 43 AFS have similar characteristics to mesenchymal stem cells derived from bone marrow and lipid tissue, including a pyramidal morphology typical of fibroblast-like cells. 40 We injected AFS into the amniotic cavity of chick embryos at Days 15e18 and detected AFS in the liver, lungs, heart, kidneys, leg muscles, and wings within 10 minutes of injection. Fewer stem cells were detected in the brain, probably due to the bloodebrain barrier. The result implies a low capacity for self-repair when the brain is damaged after birth. In addition, a study demonstrated that AFS could be found in intestine, heart, liver, lung, spleen, and bone tissue after intraperitoneal injection. 44 These experiments indicate that AFS are able to move freely into fetal tissues. Why do diverse progenitor cells present in AF at different stages of embryonic development? This article suggests that the reasonable explanation is that AF may play a role in transporting stem cells to fetal tissues during embryonic development.
In conclusion, the evidence mentioned above has shown that AF contains a number of proteins or peptides, including growth factors or cytokines that possess potent bioactivity on cellular growth and proliferation. Recently, a variety of pluripotent stem cells have been identified in AF. For the first time, this article speculates that AF may act as a transporting pathway for signaling molecules and stem cells during the embryonic development of amniotes. Defining this novel function of AF is potentially significant for further understanding embryonic development and regenerative medicine, preventing genetic diseases, and developing therapeutics for human malignancies.
